CHISON MEDICAL(SH:688358) Sou Hu Cai Jing·2025-08-19 12:05Core Viewpoint - Xiangsheng Medical (688358) has shown a slight increase in stock price, with a closing price of 33.92 yuan on August 19, 2025, reflecting a 0.95% rise, amidst mixed capital flows [1][2]. Financial Performance - The company reported a main revenue of 128 million yuan for Q1 2025, a year-on-year decrease of 9.16% [3]. - The net profit attributable to shareholders was 41.61 million yuan, down 8.62% year-on-year [3]. - The net profit after deducting non-recurring items was 38.87 million yuan, a decline of 13.38% year-on-year [3]. - The company's debt ratio stands at 9.84% [3]. Market Position - Xiangsheng Medical's total market capitalization is 3.803 billion yuan, significantly lower than the industry average of 12.117 billion yuan, ranking 95th out of 123 in the medical device industry [3]. - The company's net assets amount to 1.462 billion yuan, compared to the industry average of 3.898 billion yuan, ranking 86th [3]. - The price-to-earnings ratio (P/E) is 22.85, which is considerably lower than the industry average of 81.45, ranking 13th [3]. - The price-to-book ratio (P/B) is 2.82, compared to the industry average of 4.08, ranking 57th [3]. - The gross margin is 61.33%, higher than the industry average of 51.3%, ranking 48th [3]. - The net margin is 32.58%, significantly above the industry average of 10.7%, ranking 13th [3]. - Return on equity (ROE) is 2.89%, compared to the industry average of 1.28%, ranking 27th [3]. Capital Flow Analysis - On August 19, 2025, the net inflow of main funds was 2.2215 million yuan, accounting for 2.85% of the total transaction amount [1][2]. - Retail investors contributed a net inflow of 1.0292 million yuan, representing 1.32% of the total transaction amount [1][2]. - Over the past five days, the stock has experienced fluctuations in capital flow, with notable outflows from retail and speculative funds on certain days [2].